Hospital Universitario Infanta Leonor   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Madrid Spain (2008)

Organization Overview

First Clinical Trial
2011
NCT01299922
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Fundación para la Investigación e Innovación Biomédica del Hospital Universitario Infanta Leonor | Hospital Infanta Leonor | Hospital Universitario Infanta Leonor | Infanta Leonor University Hospital | Nephrology department. Hospital universitario Infanta Leonor

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 4)

Breast Neoplasms (Phase 2)

Infections (Phase 2)

Lupus Nephritis (Phase 3)

Nephritis (Phase 3)

Neurotoxicity Syndromes (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 11